Pharmaron (San Diego) Lab Services LLC
Carlsbad, CA Part of Pharmaron (Exton) Lab Services LLC
- UEI
- MMXQBTUNPEH3
- CAGE
- 1SDX7
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Pharmaron (Exton) Lab Services LLC · Exton, PA
G7FBJ3M3JFF3
-
Parent
Pharmaron (Exton) Lab Services LLC · Exton, PA
G7FBJ3M3JFF3
- SAM.gov registration date
- Physical address
- 2820 Loker Ave E, Carlsbad, CA 92010, USA
- Website
- pharmaron.com
- Employees
- 1K-5K
- Estimated annual revenue
- $250M-$500M
- Industry
-
- Industrials
- Capital Goods
- Industrial Conglomerates
- Industrials & Manufacturing
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $1,176,420 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $1,176,420 |
Contract awards
Similar vendors
About the company
Pharmaron (San Diego) Lab Services LLC is a division of Pharmaron (Exton) Lab Services LLC, which does business as Absorption Systems. Pharmaron is a global contract research organization that provides research and development and manufacturing services to support the life sciences industry. Through federal contract awards, Pharmaron (San Diego) Lab Services LLC provides pharmacokinetic, pharmacodynamic, drug metabolism, and analytical testing services.
Pharmaron (San Diego) Lab Services LLC has received federal contract awards from the Department of Health and Human Services, including the Food and Drug Administration (FDA) and National Institutes of Health. These have included a $434,414 firm fixed price delivery order from the FDA for permeability assessments of drug substances; a $24,805 purchase order from the National Institutes of Health National Center for Advancing Translational Sciences for pharmacokinetics testing; and a $1.6 million delivery order from the FDA to conduct pharmacokinetic and pharmacodynamic studies in rabbits to evaluate ophthalmic drug formulations. Pharmaron (San Diego) Lab Services LLC has also received a $336,146 FDA delivery order to measure ocular surface tear film thickness in rabbits after exposure to cyclosporine ophthalmic emulsion. Through these awards, Pharmaron (San Diego) Lab Services LLC provides data to the FDA and NIH to support the evaluation and regulation of pharmaceutical products.
Quick answers
Is Pharmaron (San Diego) Lab Services LLC registered in SAM.gov?
Yes. Pharmaron (San Diego) Lab Services LLC's SAM.gov registration is active through April 29, 2027.
How much has Pharmaron (San Diego) Lab Services LLC received in federal contracts?
Federal contracts obligated $1,176,420 to Pharmaron (San Diego) Lab Services LLC in fiscal years 2023 through 2027.
What is Pharmaron (San Diego) Lab Services LLC's most recent federal award?
Pharmaron (San Diego) Lab Services LLC's most recent federal contract award is Neural stem cell study for spinal cord injury (36C24E26C0013), from Veterans Integrated Service Network 4 (VHA), on September 17, 2026.
On GovTribe
See Pharmaron (San Diego) Lab Services LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors